Mucus Relief - Dm
Product Images NDC 73581-404

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mucus Relief - Dm (NDC 73581-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yyba Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Df1 (01b Lbl (df1) Welmate Mucus Relief Dm Max 50ct G7554 050 103 0)

Purpose: The text contains warnings and instructions for the use of extended-release tablets that include DetrmettianHyikromide and Guesinesin. The tablets are meant to help loosen mucus and clear bronchial passages for easier breathing. The text warns against using the tablets if the printed seal under the AP is missing or damaged, and advises users to look for directions on the tablet peel. The text also cautions that certain symptoms such as fever, rashes, and persistent headaches could be signs of a serious condition and advises users to seek medical attention.*

FDA Label Image

Df2 (01b Lbl (df2) Welmate Mucus Relief Dm Max 50ct G7554 050 103 0)

FDA Label Image

Pdp (01b Lbl (pdp) Welmate Mucus Relief Dm Max 50ct G7554 050 103 0)

This is a description of a medication that is a generic equivalent of Maximum Strength Mucinex DM, an expectorant and cough suppressant. The active ingredients are identified as 1200mg Guaifenesin and 60mg Dextromethorphan HBr. The medication is in the form of extended-release tablets that help to control cough and thin and loosen mucus.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.